Current evaluation of amenorrhea

Fertility and Sterility

Volumn 82, Issue SUPPL. 1, 2004, Pages 33-39

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIFENE CITRATE; DOPAMINE RECEPTOR STIMULATING AGENT; ESTROGEN; FOLLITROPIN; GESTAGEN; GONADORELIN; GONADOTROPIN; ORAL CONTRACEPTIVE AGENT; PROLACTIN; THYROTROPIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADRENAL DISEASE; ADRENAL HYPERPLASIA; AMENORRHEA; ANDROGEN INSENSITIVITY SYNDROME; ANOREXIA; ANOVULATION; AUTOIMMUNE DISEASE; BRAIN DISEASE; BREAST DEVELOPMENT; CUSHING SYNDROME; EMPTY SELLA SYNDROME; ENDOMETRIOSIS; ESTROGEN DEFICIENCY; EVALUATION; GENITAL SYSTEM EXAMINATION; GLUCOSE INTOLERANCE; GONAD DYSFUNCTION; GONADAL AGENESIS; GONADAL DYSGENESIS; GONADOTROPIN DEFICIENCY; HUMAN; HYPERANDROGENISM; HYPERINSULINEMIA; HYPERPROLACTINEMIA; HYPOGONADOTROPIC HYPOGONADISM; HYPOPHYSIS TUMOR; HYPOPITUITARISM; HYPOTHALAMUS FUNCTION DISORDER; JUVENILE DIABETES MELLITUS; KALLMANN SYNDROME; KIDNEY FAILURE; MALABSORPTION; MENARCHE; OLIGOMENORRHEA; OSTEOPOROSIS; OVARY POLYCYSTIC DISEASE; OVARY TUMOR; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; PROLACTINOMA; REVIEW; UROGENITAL TRACT MALFORMATION; UTERUS SYNECHIA; VAGINA APLASIA;

EID: 4444382170     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2004.07.001     Document Type: Article

References (53)

1. Stedman's Medical Dictionary. 27th ed. Philadelphia: Lippincott Williams & Wilkins, 2000:56
2. Herman-Giddens M.E., Slora E.J., Wasserman R.C., Bourdony C.J., Bhapkar M.V., Koch G.G., et al. Secondary sexual characteristics and menses in young girls seen in office practice a study from the Pediatric Research in Office Settings network. Pediatrics. 99:1997;505-512
3. Pettersson F., Fries H., Nillius S.J. Epidemiology of secondary amenorrhea. I. Incidence and prevalence rates. Am J Obstet Gynecol. 117:1973;80-86
4. Bachmann G., Kemmann E. Prevalence of oligomenorrhea and amenorrhea in a college population. Am J Obstet Gynecol. 144:1982;98-102
5. Reindollar R.M., Byrd J.R., McDonough P.G. Delayed sexual development a study of 252 patients. Am J Obstet Gynecol. 140:1981;371-380
6. Reindollar R.H., Novak M., Tho S.P., McDonough P.G. Adult-onset amenorrhea a study of 262 patients. Am J Obstet Gynecol. 155:1986;531-543
7. Mashchak C.A., Kletzky O.A., Davajan V., Mishell D.R. Clinical and laboratory evaluation of patients with primary amenorrhea. Obstet Gynecol. 57:1981;715-721
8. Insler V. Gonadotophin therapy new trends and insights. Int J Fertil. 33:1988;85-97
9. Doody K.M., Carr B.R. Amenorrhea. Obstet Gynecol Clin North Am. 17:1990;361-387
10. Jagiello G. Prevalence of testicular feminization. Lancet. 1:1962;329
11. Wilson J.D. Syndromes of androgen resistance. Biol Reprod. 46:1992;168-173
12. Lobo RA. Primary and secondary amenorrhea. In: Fraser IS, Jansen R, Lobo RA, Whitehead M, eds. Estrogens and progestogens in clinical practice. London: Churchill Livingstone, 1998
13. Reid RL. Amenorrhea. In: Copeland LJ, ed. Textbook of gynecology. 2nd ed. Philadelphia: WB Saunders, 1996
14. Manuel M., Katayama P.K., Jones H.W. Jr. The age of occurrence of gonadal tumors in intersex patients with a Y chromosome. Am J Obstet Gynecol. 124:1976;293-300
15. Turner H.H. A syndrome of infantilism, congenital webbed neck, and cubitus valgus. Endocrinology. 23:1938;566
16. Turner's syndrome. West J Med 1982;137:32-44
17. Toledo S.P., Brunner H.G., Kraaij R., Post M., Dahia P.L., Hayashida C.Y., et al. An inactivating mutation of the luteinizing hormone receptor causes amenorrhea in a 46,XX female. J Clin Endocrinol Metab. 81:1996;3850-3854
18. Aittomaki K., Lucena J.L., Pakarinen P., Sistonen P., Tapanainen J., Gromoll J., et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell. 82:1995;959-968
19. Allingham-Hawkins D.J., Babul-Hirji R., Chitayat D., Holden J.J., Yang K.T., Lee C., et al. Fragile X premutation is a significant risk factor for premature ovarian failure the International Collaborative POF in Fragile X study - preliminary data. Am J Med Genet. 83:1999;322-325
20. Laml T., Preyer O., Umek W., Hengstschlager M., Hanzal H. Genetic disorders in premature ovarian failure. Hum Reprod Update. 8:2002;483-491
21. Morishima A., Grumbach M.M., Simpson E.R., Fisher C., Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab. 80:1995;3689-3698
22. Jones G.S., De Moraes-Ruehsen M. A new syndrome of amenorrhea in association with hypergonadotropism and apparently normal ovarian follicular apparatus. Am J Obstet Gynecol. 104:1969;597-600
23. Van Campenhout J., Vauclair R., Maraghi K. Gonadotropin-resistant ovaries in primary amenorrhea. Obstet Gynecol. 40:1972;6-12
24. Conway G.S., Kaltsas G., Patel A., Davies M.C., Jacobs H.S. Characterization of idiopathic premature ovarian failure. Fertil Steril. 65:1996;337-341
25. Laml T., Preyer J., Umek W., Hengstschlager M., Hanzal E. Genetic disorders in premature ovarian failure. Hum Reprod Update. 8:2002;483-491
26. LaBarbera A.R., Miller M.M., Ober C., Rebar R.W. Autoimmune etiology in premature ovarian failure. Am J Reprod Immunol Microbiol. 16:1988;115-122
27. Hoek A., Schoemaker J., Drexhage H.A. Premature ovarian failure and ovarian autoimmunity. Endocr Rev. 18:1997;107-134
28. Nelson L.M., Anasti J.N., Flack M.R. Premature ovarian failure. Adashi E.Y., Rock J.A., Rosenwaks Z. Reproductive endocrinology, surgery, and technology. 1996;1393-1410 Lippincott-Raven, Philadelphia
29. Rebar R.W., Connolly H.V. Clinical features of young women with hypergonadotropic amenorrhea. Fertil Steril. 53:1990;804-810
30. Touraine P., Plu-Bureau G., Beji C., Mauvais-Jarvis P., Kuttenn F. Long-term follow-up of 246 hyperprolactinemic patients. Acta Obstet Gynecol Scand. 80:2001;162-168
31. Brenner S.H., Lessing J.B., Quagliarello J., Weiss G. Hyperprolactinemia and associated pituitary prolactinomas. Obstet Gynecol. 65:1985;661-664
32. Schlechte J., Dolan K., Sherman B., Chapler F., Luciano A. The natural history of untreated hyperprolactinemia a prospective analysis. J Clin Endocrinol Metab. 68:1989;412-418
33. Marshall J.C., Eagleson C.A., McCartney C.R. Hypothalamic dysfunction. Mol Cell Endocinol. 183:2002;29-32
34. Imani B., Eijkemans M.J., te Velde E.R., Habbema J.D., Fauser B.C. A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. Fertil Steril. 77:2002;91-97
35. Rarick L.D., Shangold M.M., Ahmed S.W. Cervical mucus and serum estradiol as predictors of response to progestin challenge. Fertil Steril. 54:1990;353-355
36. Nakamura S., Douchi T., Oki T., Ijuin H., Yamamoto S., Nagata Y. Relationship between sonographic endometrial thickness and progestin-induced withdrawal bleeding. Obstet Gynecol. 87:1996;722-725
37. Frisch R.E., McArthur J.W. Menstrual cycles fatness as a determinant of minimum weight for height necessary for their maintenance or onset. Science. 185:1974;949-951
38. Lucas A.R., Crowson C.S., O'Fallon W.M., Melton L.J. 3rd. The ups and downs of anorexia nervosa. Int J Eat Disord. 26:1999;397-405
39. Warren M.P., Goodman L.R. Exercise-induced endocrine pathologies. J Endocrinol Invest. 26:2003;873-878
40. Rosenfield R.L. Clinical review 6 diagnosis and management of delayed puberty. J Clin Endocrinol Metab. 70:1990;559-562
41. Hall J.E. Physiologic and genetic insights into the pathophysiology and management of hypogonadotropic hypogonadism. Ann Endocrinol. 60:1999;93-101
42. Layman L.C., McDonough P.G., Cohen D.P., Maddox M., Tho S.P., Reindollar R.H. Familial gonadotropin-releasing hormone resistance and hypogonadotropic hypogonadism in a family with multiple affected individuals. Fertil Steril. 75:2001;1148-1155
43. Sheehan H.L. Simmond's disease due to post-partum necrosis of the anterior pituitary. Q J Med. 8:1939;277
44. Davies M.C., Hall M.L., Jacobs H.S. Bone mineral loss in young women with amenorrhoea. BMJ. 301:1990;790-793
45. Martin K.A., Hall J.E., Adams J.M., Crowley W.F. Jr. Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea. J Clin Endocrinol Metab. 77:1993;125-129
46. Moran C., Azziz R., Carmina E., Dewailly D., Fruzzetti F., Ibanez L., et al. 21-Hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder a multicenter study. Am J Obstet Gynecol. 183:2000;1468-1474
47. Legro R.S. Polycystic ovary syndrome the new millennium. Mol Cell Endocrinol. 184:2001;87-93
48. Bili H., Laven J., Imani B., Eijkemans M.J., Fauser B.C. Age-related differences in features associated with polycystic ovary syndrome in normogonadotrophic oligo-amenorrhoeic infertile women of reproductive years. Eur J Endocrinol. 145:2001;749-755
49. Zawadzki J.K., Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. Dunaif A., Givens J.R., Haseltine F.P., Merriam G.M. Polycystic ovary syndrome. 1992;377-384 Blackwell, Boston
50. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 81:2004;19-25
51. Dunaif A., Thomas A. Current concepts in the polycystic ovary syndrome. Annu Rev Med. 52:2001;401-419
52. Legro R.S., Kunselman A.R., Dodson W.C., Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab. 84:1999;165-169
53. Dunaif A., Finegood D.T. Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J Clin Endocrinol Metab. 81:1996;942-947